Florian Wegwitz

21PUBLICATIONS
87CO-AUTHORS
Molecular targetsHaematological tumoursCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 12, 2026
Targeting PRMT5 inhibitor-induced adaptation in pancreatic cancer with the RBM39 degrader indisulam.

|Jun 17, 2026
PTHrP-associated hypercalcemia in gynecologic malignancies: a scoping review.

|Jun 05, 2026
Identification of tumor-promoting functions of the Homeobox family transcription factor MSX1 in cervical cancer.

|Apr 18, 2026
MUC1 as a Survival Effector of Radiotherapy-Induced Epithelial Hybrid States in Basal-Like Breast Cancer.

|Apr 09, 2025
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.

Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz

|Mar 11, 2024
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.

Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz

Pageof 4

Frequent Collaborators

6 joint publications

Steven A Johnsen

6 joint publications

Evangelos Prokakis

5 joint publications

Robyn Laura Kosinsky

3 joint publications

Ramona Schulz-Heddergott